HBOT Marketing Built Around the FDA-Cleared Indications

HBOT clinic marketing combines local SEO, Google Business Profile optimization, Meta and Google paid media, referral network development with chiropractors and sports medicine physicians, and membership and package conversion funnels. The campaign architecture splits into two funnels: a clinical-indication funnel for FDA-cleared uses (wound care, diabetic ulcers, radiation damage) and a wellness funnel for off-label uses (longevity, sports recovery, cognitive performance) marketed under the FDA's General Wellness Policy. Each funnel has different creative, different landing pages, and different compliance language because the regulatory frame and the buyer are different.

HBOT is FDA-cleared for 13 specific indications: carbon monoxide poisoning, decompression sickness, gas gangrene, acute traumatic ischemia, crush injury, diabetic foot ulcers, radiation tissue damage, chronic refractory osteomyelitis, compromised skin grafts and flaps, severe anemia, intracranial abscess, thermal burns, and sudden hearing loss. Other uses (sports recovery, longevity, cognitive performance, anti-inflammation, brain health) are off-label and must be marketed under the FDA's General Wellness Policy without making treatment claims. The FDA "Get the Facts" consumer alert specifically warned against marketing HBOT for autism, cancer, Lyme disease, and Alzheimer's.

The 13 FDA-cleared indications for HBOT are carbon monoxide poisoning, decompression sickness, gas gangrene, acute traumatic ischemia, crush injury, diabetic foot ulcers, radiation tissue damage, chronic refractory osteomyelitis, compromised skin grafts and flaps, severe anemia, intracranial abscess, thermal burns, and sudden hearing loss. These indications can be marketed directly with specific clinical claims and proper substantiation. Off-label uses (sports recovery, longevity, anti-aging, cognitive performance, brain injury recovery) cannot be marketed as treatments and must be framed as wellness applications.

Yes, you can advertise HBOT on Meta and Google for FDA-cleared indications with proper substantiation. Off-label HBOT marketing must follow Meta's Personal Health policy (no "you" framing for medical conditions) and Google's Healthcare and Medicines policy. Specific banned claims include treating autism, cancer, Lyme disease, Alzheimer's, and similar uses where the FDA has issued warning letters. Some HBOT chambers (1.3 ATA soft-shell) are marketed as wellness devices under the FDA's General Wellness Policy with explicit wellness language. We write HBOT ad copy that respects both the platform policy and the underlying FDA frame.

The FDA has issued multiple warning letters to HBOT centers marketing off-label uses without proper substantiation, particularly for autism, cancer, Lyme disease, traumatic brain injury, and Alzheimer's claims. The Sands Hyperbaric Systems warning letter is one of the most-cited examples. The FTC has also issued warning letters for Lyme disease HBOT marketing. The enforcement pattern: claims of treating a specific disease without FDA approval, before-and-after testimonials without substantiation, or marketing that implies a medical condition the FDA has not cleared HBOT for. Compliant HBOT marketing stays inside the cleared indications or uses the General Wellness Policy frame.

Pricing varies by clinic size, number of chambers, ad spend, and channel mix. A typical single-location HBOT clinic runs $2,500 to $6,000 per month in retainer plus a comparable ad spend budget, with performance-based or hybrid retainer-plus-commission pricing depending on the plan. Multi-location HBOT networks and clinics adding membership programs run higher budgets. Raging Agency does not publish a generic price sheet because HBOT clinics with FDA-cleared indication focus, mild HBOT wellness positioning, and longevity-buyer positioning all have different unit economics. Final pricing is scoped on a Strategy Call.